FDA.reportPublic FDA data

Exparel 133 MG per 10 ML Injection

RxCUI
1745062
RxNorm name
Exparel 133 MG per 10 ML Injection
Display name
Exparel 133 MG per 10 ML Injection
Full name
Exparel 133 MG per 10 ML Injection
Term type
SY
Status
DailyMed mapping
Updated
2026-06-04 23:39:18

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
EXPARELBUPIVACAINEPacira Pharmaceuticals, Inc.bb5a9e59-0f51-11df-8a39-0800200c9a662025-12-12Warnings, Adverse reactionsExact identifier
rxcui: 1745062

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
bb5a9e59-0f51-11df-8a39-0800200c9a66EXPAREL 1.3 % in 10 ML Injection [PSN] · 10 ML bupivacaine liposome 13.3 MG/ML Injection [Exparel] [SBD] · 10 ML Exparel 13.3 MG/ML Injection [SY] · Exparel 133 MG per 10 ML Injection [SY]432These highlights do not include all the information needed to use EXPAREL® safely and effectively. See full prescribing information for EXPAREL. EXPAREL (bupivacaine liposome injectable suspension), for infiltration or perineural use Initial U.S. Approval: 197220251212